SCHEMBL6604412

SCHEMBL6604412

CCOc1ccc(C(=O)Nc2ccc3c(c2Cl)CNCC3)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.52
RAB9A P51151 4/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
MITF O75030 1/20 0.52
MAPT P10636 7/20 0.52
ALDH1A1 P00352 4/20 0.52
KDM4E B2RXH2 2/20 0.52
NPSR1 Q6W5P4 1/20 0.52
POLB P06746 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
LMNA P02545 1/20 0.50
GAA P10253 1/20 0.50
MCL1 Q07820 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
TP53 P04637 5/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8120517 0.92 NPC1 (0.46) NPC1RAB9ASMN1; SMN2MITFMAPT
SCHEMBL6602268 0.90 MAPT (0.49) NPC1RAB9ASMN1; SMN2MITFMAPT
SCHEMBL6600619 0.90 CREBBP (0.46) NPC1RAB9ASMN1; SMN2MITFMAPT
SCHEMBL5874190 0.88 MAPT (0.53) NPC1RAB9ASMN1; SMN2MITFMAPT
SCHEMBL5874020 0.81 MEN1 (0.59) NPC1RAB9ASMN1; SMN2MITFMAPT
SCHEMBL6604270 0.81 KCNQ3 (0.47) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL6602962 0.81 MAPT (0.55) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
Hydrochloric Acid SCHEMBL5874014 0.80 MEN1 (0.58) NPC1RAB9ASMN1; SMN2MITFMAPT
SCHEMBL5874018 0.80 MAPT (0.49) NPC1RAB9ASMN1; SMN2MITFMAPT
SCHEMBL5874021 0.79 MEN1 (0.56) NPC1RAB9ASMN1; SMN2MITFMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP claimed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US claimed
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP disclosed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US disclosed
EP-1042296-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-10-11 EP disclosed
WO-1999031068-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-06-24 WO disclosed